Marcin Rucinski Selected Research

Prostatic Neoplasms (Prostate Cancer)

5/2022	Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study.
10/2019	Analysis of Transcriptome, Selected Intracellular Signaling Pathways, Proliferation and Apoptosis of LNCaP Cells Exposed to High Leptin Concentrations.
1/2018	Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
1/2016	ZFP91: A Noncanonical NF-κB Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer.
1/2015	Lack of expression of preproorexin and orexin receptors genes in human normal and prostate cancer cell lines.
4/2014	ZFP91-a newly described gene potentially involved in prostate pathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcin Rucinski Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 12/2005
6	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 04/2014
4	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 02/2020
3	Adrenocortical Carcinoma 01/2024 - 12/2005
3	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2014
3	Pheochromocytoma 01/2021 - 01/2010
3	Body Weight (Weight, Body) 05/2009 - 01/2004
3	Obesity 03/2007 - 12/2005
2	Adenoma (Adenomas) 01/2018 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2015
2	Decapitation 05/2009 - 05/2008
1	Fatty Liver 05/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Hypoxia (Hypoxemia) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Uveal melanoma 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Squamous Cell Carcinoma of Head and Neck 08/2021
1	Adenocarcinoma 01/2021
1	Adrenocortical Adenoma (Disease, Conn's) 01/2021
1	Breast Neoplasms (Breast Cancer) 02/2020
1	Surgical Wound 02/2020
1	Wounds and Injuries (Trauma) 02/2020
1	Insulin Resistance 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Osteoarthritis 09/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2019
1	Carcinogenesis 01/2018
1	Myelolipoma 01/2018
1	Hyperplasia 01/2018
1	Ovarian Epithelial Carcinoma 05/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2014
1	Dosage-sensitive sex reversal 03/2014
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2011
1	Pain (Aches) 12/2009
1	Insulinoma 10/2009
1	Myoma 12/2005

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2005
5	MicroRNAs (MicroRNA)IBA 05/2022 - 04/2020
5	LeptinIBA 10/2019 - 12/2005
5	Messenger RNA (mRNA)IBA 03/2019 - 12/2005
3	Leptin ReceptorsIBA 01/2018 - 12/2005
3	4-nitrophenethyl bromide (NPB)IBA 12/2009 - 12/2005
2	Hormones (Hormone)IBA 01/2024 - 03/2007
2	Peptides (Polypeptides)IBA 10/2023 - 03/2011
2	Topotecan (Hycamtin)FDA LinkGeneric 05/2022 - 04/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022 - 04/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 04/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2021
2	GhrelinIBA 01/2021 - 01/2018
2	AntigensIBA 01/2020 - 05/2014
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2007
2	AldosteroneIBA 01/2015 - 01/2004
2	CalciumIBA 01/2015 - 10/2009
2	Orexin ReceptorsIBA 01/2015 - 03/2011
1	Choline (Choline Chloride)IBA 05/2024
1	humaninIBA 01/2024
1	oxidized low density lipoproteinIBA 01/2024
1	12S ribosomal RNAIBA 10/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	caperatic acidIBA 01/2022
1	CateninsIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021
1	major vault proteinIBA 11/2021
1	vault poly(ADP-ribose) polymeraseIBA 11/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2021
1	RNA (Ribonucleic Acid)IBA 08/2021
1	Conditioned Culture MediaIBA 02/2020
1	ResveratrolIBA 02/2020
1	3,4,5,4'-tetramethoxystilbeneIBA 02/2020
1	StilbenesIBA 02/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	VaccinesIBA 01/2020
1	AndrogensIBA 10/2019
1	SolutionsIBA 09/2019
1	Complementary DNA (cDNA)IBA 03/2019
1	Differentiation AntigensIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2016
1	visininIBA 01/2015
1	EnzymesIBA 05/2014
1	ImmunosorbentsIBA 05/2014
1	ChemokinesIBA 05/2014
1	CXCR4 Receptors (CXCR4 Receptor)IBA 05/2014
1	Transcription Factors (Transcription Factor)IBA 04/2014
1	OrexinsIBA 03/2011
1	Natriuretic PeptidesIBA 01/2010
1	ColforsinIBA 10/2009
1	Insulin (Novolin)FDA Link 03/2007
1	CytokinesIBA 01/2007
1	NeuropeptidesIBA 12/2005

Therapy/Procedure

2	Radiotherapy 05/2022 - 02/2020
2	Subcutaneous Injections 05/2009 - 05/2008
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2022
1	Segmental Mastectomy (Lumpectomy) 02/2020
1	Therapeutics 01/2016
1	Cystectomy 04/2014
1	Intraperitoneal Injections 05/2009